Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Death Receptor-5"”.
-
Characterization Of The Interactions Of Calmodulin With Fas And Death Receptor-5, And Determine The Role Of Calmodulin - Death Receptor-5 Binding In Disc Formation In Breast Cancer.
… Fas and DR-5 mediated apoptosis. The Fas receptor apoptotic pathway has been well characterized in cholangiocarcinoma; however, targeting Fas for anti-cancer therapy has shown hepatotoxicity in vivo. Thus, in vitro studies with breast cancer will focus on the DR-5 mediated apoptotic …
-
Role Of Calmodulin In Death Receptor 5-Mediated Apoptosis In Breast Cancer
Drug resistant estrogen receptor positive (ER-positive) and triple-negative (TN) breast cancers, are prolific breast cancers with poor clinical outcome. TRA-8 is a death receptor-5 (DR5) specific agonistic antibody with tumoricidal activity in vitro and in vivo, without inducing normal hepatocyte …
-
The Death Receptor 5 regulates 5-FU-induced apoptosis via the p38 SAPK pathway
… through p53-dependent upregulation of TRAILreceptor 2 (TRAIL-R2) also known as Death Receptor 5 (DR5), leading to a partial activation of the receptor independent of its ligand TRAIL. This activation triggers non-canonical signalling including the p38 MAPK pathway, which is absent or …
-
Regulation of cytotoxic drug-induced apoptosis by death receptor 5 in human colon cancer cells
… drugs such as 5-FU are thought to trigger cell death via the intrinsic apoptosis pathway which involves caspase-9 activation as one of the initiating molecular events. However, our group recently found the new apoptotic pathways which are involved in 5-FU-induced apoptosisin which caspase-8 is …
-
Synthetic Methodologies for Molecular Imaging: Synthesis, Cyclization and In Vitro Binding Study of Death Receptor 5 Targeted Peptides
… anticancer ligand that can biologically bind to Death Receptor 5 (DR5). Studies have showed that colorectal cancers have significant DR5 upregulation. Except in oncology, liver fibrosis is also relevant to TRAIL, which is a common chronic liver disease that will lead to liver cirrhosis and …
-
Sensitization of glioma to death receptor 5-mediated apoptosis through genotoxic stress and cell cycle disruption: A study of mechanism
Our laboratory reported that a combination of ionizing radiation (IR) or temozolomide (Tmz), a DNA methylating agent clinically approved against glioblastoma multiforme (GBM), a type of human brain cancer, and TRA-8, an anti-DR5 monoclonal antibody produced synergistic cytotoxicity in GBM cells in …
-
Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/ß-Catenin Signaling In Basal-Like Breast Cancer Stem Cells
… antibody that binds specifically to TRAIL death receptor 5, preferentially induces apoptosis in BLBC subtype cells; however it is unknown if TRA-8 is also cytotoxic to the CSC population. Moreover, some BLBC cell lines are resistant to TRA-8, and overcoming resistance is critical for …
-
The Use of Molecular Imaging to Evaluate te Efficacy of Treatments for Metastatic Breast Cancer
… imaging to evaluate the efficacy of Death Receptor 5 agonist therapy for the treatment of breast cancer metastasis, predominately to the skeleton, in an athymic nude mouse model. Initially, we determined that bioluminescence imaging was the most ideal technology for studying secondary …
-
MOLECULAR IMAGING OF INFLAMMATION-RELATED BIOMARKERS IN CANCER, FIBROSIS, AND NEURODEGENERATIVE DISEASE
… disease (nicotinic acetylcholine receptors and soluble epoxide hydrolase), and fibrosis (death receptor 5). We aim to show the feasibility and importance of these efforts in the following 6 chapters. In chapter 1, we provide an introduction to molecular imaging, discuss …
-
Integrating Protein Engineering and Genomics for Cancer Therapy
… cancer resistance to protein agonists of death receptor 5 (DR5), a key upregulated marker in colorectal cancer (CRC). Over the past decade, various DR5 agonists have shown poor clinical efficacy, including both engineered antibodies and TRAIL, the natural ligand for this receptor. …
-
MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME
… MSC (MSC-TRAIL) and CBX enhanced glioma cell death, especially in two primary human glioma isolates that are marginally sensitive to TRAIL. CBX enhanced TRAIL-induced apoptosis through CHOP-mediated upregulation of death receptor 5 and downregulation of anti-apoptotic Bcl-2. CBX also blocked …
-
Effect Of The Combined Treatment Of Tra-8, An Agonistic Dr5 Antibody, And Tamoxifen On Breast Cancer Cells
… women and is the second leading cause of cancer death in the United States. The disease affects an estimated 1.3 million women annually worldwide. Some breast cancer cells have developed mechanisms of circumventing drug treatment. Clinical needs for breast cancer cell sensitization to anti-cancer …
-
Development of novel antibody-targeted nanoparticle strategies for treatment of pancreatic cancer
… the TNF-related apoptosisinducing ligand (TRAIL) receptor 2/ death receptor-5 (DR5) pathway using the monoclonal antibody conatumumab (AMG 655). However, the results of these clinical trials proved disappointing with no survival advantage being observed. Subsequent literature has suggested that …
-
Targeting Pathological Protein Interactions in Drug Discovery
… platform that detects structural changes in death receptor 5 (DR5), a membrane protein which regulates apoptosis. In this chapter we have identified small-molecules which modulate DR5 signaling and sensitize TRAIL-resistant cancer cells to TRAIL-induced apoptosis. In chapter 3, the same HTS …
-
Targeting triple negative human breast cancer with omega-3 docosahexaenoic acid (DHA) and tocotrienol
… binding protein) homologous protein (CHOP)/death receptor-5 (DR5) pro-apoptotic signaling involving caspases-8 and 9. DHA eliminated TICs as measured by elimination of aldehyde dehydrogenase active (ALDH⁺) population and inhibition of mammosphere formation. DHA eliminated TICs via …
-
Extending the scope of covalent peptide-protein conjugation: from purification to expanded nanoassembly
… assemblies. An agonistic nanobody against Death Receptor 5 was multimerised through SpyCatcher002-oligomers and showed a stoichiometry-dependent effect on breast cancer cell line apoptosis upon receptor activation.</p>
-
Conformational Dynamics Associated with Signaling in Tumor Necrosis Factor Receptors
The long accepted model for tumor necrosis factor receptor (TNFR) signaling is that ligand binding causes receptors to trimerize, resulting in a stoichiometric change in their cytosolic domains. This model is incomplete in that it does not explain the importance of receptor self-interaction nor …
-
The Anti-Tumor Effects Of Hur Inhibition In Glioblastoma
… produces a dose-dependent toxicity through the death receptor 5 (DR5) pathway, a decrease in GSC frequency, attenuation of cell migration at sublethal doses and inhibited expression of key growth factors and cytokines. In the second part of the project, we generated a tissue specific HuR …
Page 1 of 2